SCHEMBL27204277

SCHEMBL27204277

CN(C)C1CCOc2ccc(Br)cc21

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADRA2A P08913 3/20 0.47
▸ MAPT P10636 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ IMPDH2 P12268 1/20 0.36
▸ HTR2A P28223 4/20 0.35
▸ HTR2C P28335 4/20 0.35
▸ DRD2 P14416 3/20 0.35
▸ DRD3 P35462 2/20 0.35
▸ ADRA2C P18825 1/20 0.35
▸ DRD1 P21728 1/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ HRH1 P35367 1/20 0.35
▸ HCRTR2 O43614 1/20 0.34
▸ AHR P35869 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30816242 1.00 ADRA2A (0.47) ADRA2AMAPTHTTLMNABLM
SCHEMBL27159912 1.00 ADRA2A (0.47) ADRA2AMAPTHTTLMNABLM
SCHEMBL29914802 0.83 DRD2 (0.41) ADRA2AMAPTHTTLMNABLM
SCHEMBL27204312 0.83 DRD2 (0.41) ADRA2AMAPTHTTLMNABLM
SCHEMBL27159712 0.83 DRD2 (0.41) ADRA2AMAPTHTTLMNABLM
SCHEMBL31395451 0.83 ADRA2A (0.41) ADRA2AMAPTHTTLMNABLM
SCHEMBL25202695 0.78 ADRA2A (0.50) ADRA2AMAPTHTTLMNABLM
SCHEMBL803154 0.76 ITGB2 (0.41) HTTLMNA
SCHEMBL30134460 0.76 ADRA2A (0.51) ADRA2AMAPTHTTLMNABLM
SCHEMBL24916258 0.76 ADRA2A (0.51) ADRA2AMAPTHTTLMNABLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240425479-A1 HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-12-26 — — US disclosed
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 — — US disclosed
EP-4330246-A1 HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) Ontario Institute for Cancer Research (OICR) (CA) 2024-03-06 — — EP disclosed
WO-2022226665-A1 HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 — — WO disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 ADRA2A 3918/4885MAPT 3643/4885HTT 1966/4885
US-20240425479-A1 HALO-SUBSTITUTED AMINO AZA-HETEROARYL COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) DCK, CMPK1, WNK1 ADRA2A 3182/4885MAPT 4500/4885HTT 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback